Medtronic Partners With Rune Labs To Explore New Frontiers In Deep Brain Stimulation
Rune Labs will collect data from 1,000 patients fitted with Medtronic’s Percept DBS device and search for previously unknown patterns in Parkinson’s disease patients.
You may also be interested in...
In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.
The diagnostic company has secured more government funding for DeepView, a product it has developed to assess the healing of certain types of wound. In total, BARDA has supported SpectralMD with almost a quarter of a billion dollars.
The surgical robotics start-up may be de-listed from the New York Stock Exchange (NYSE) due to its low current share price. Some analysts believe the company can survive long enough to earn FDA de novo clearance for its robotic surgical system.